Peptides DB
Research-centric peptide and protocol reference hub
Study 38 of 40VIP (Vasoactive Intestinal Polypeptide) literatureEndocrinology, diabetes & metabolism case reports · Case reportHigh-impact journal2026

Composite pheochromocytoma-ganglioneuroma secreting vasoactive intestinal peptide.

This case highlights a rare occurrence of VIP secretion in a composite pheochromocytoma-ganglioneuroma, with normalization of VIP levels following surgical intervention.

Read at Endocrinology, diabetes & metabolism case reportsAdd to compare

Where it sits

this study against the rest of the vip (vasoactive intestinal polypeptide) corpus
8
Preclinical
25
Observational · this one
1
Open-label
2
Randomised
4
Reviews

Summary and findings

An 80-year-old female with a 10-year history of diarrhea and chronic hyponatremia was found to have a 6.8-centimeter right adrenal mass. Elevated levels of vasoactive intestinal peptide (VIP) were noted, and surgical resection confirmed a composite pheochromocytoma-ganglioneuroma. Postoperatively, plasma levels of VIP and normetanephrines normalized, along with resolution of diarrhea and other symptoms.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Maximal SUV of 14.4.2026

Abstract

The authors’ words, as Endocrinology, diabetes & metabolism case reports supplied them

<h4>Summary</h4>An 80-year-old female patient presented with a 10-year history of progressively worsening diarrhea and chronic hyponatremia. An abdominal computed tomography (CT) revealed a 6.8-centimeter right adrenal mass. A Ga-68 DOTATATE positron emission tomography (PET)/CT scan subsequently demonstrated a significant expression of somatostatin receptors on the tumoral shell (maximal SUV of 14.4), associated with a hypometabolic central portion. Endocrine investigation indicated elevated levels of both urinary and plasmatic normetanephrines. Given the watery diarrhea, VIP levels were measured, which were markedly elevated. Surgical resection confirmed a composite pheochromocytoma-ganglioneuroma with VIP immunoreactivity in both tumor components. In the postoperative period, the plasma levels of VIP and normetanephrines returned to normal with resolution of diarrhea, hyponatremia, and hypertension. This case illustrates a rare instance of composite pheochromocytoma-ganglioneuroma with co-secretion of catecholamines and VIP, with evidence of VIP production in both tumor components. The finding of VIP secretion in the pheochromocytoma and the ganglioneuroma suggests that both tumors might originate from the same cell of neural crest origin.<h4>Learning points</h4>

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the VIP (Vasoactive Intestinal Polypeptide) corpus

DClinical update: Assessment and management of Helicobacter pylori infection.BMJ (Clinical research ed.) · 2026reviewCGlycine transporter 1 inhibitor, bitopertin, changes excitatory and inhibitory network connectivity in mouse medial prefrontal cortex.Neuropharmacology · 2026 · Not reported in abstract.AnimalBOral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial.Nature medicine · 2026HumanBVagal cholinergic denervation of the gastric mucosa in Long-COVID-19: In vivo evidence of structural autonomic dysfunction.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026 · 2.1 nm/µm³ vs 3.9 nm/µm³ in fundus, P < 0.01HumanCLiangfu Pill Alleviates Constipation-Predominant Irritable Bowel Syndrome through Modulation of 5-HT Signaling Pathway and Gut Microbiota.Chinese journal of integrative medicine · 2026 · P<0.05 or P<0.01 for various measured outcomes.AnimalBAtlas-Guided Cell-Specific Transcriptomics Identifies Pathway-Level Remodeling of Human Hypothalamic CRH Neurons in Opioid Use Disorderbiorxiv-preprint · 2026 · n=343819 · Nominal decrease in VIP, not quantified.Human